SBIR/STTR Research Award

SBIR Phase I: Use of Phase-Transition Biopolymers as Novel Enzyme Carriers for Biocatalysis

Award identifier 4bdf36346d226a56a5e065bdb11b7b2622b2c2faf67c7e1b5b779d69c77a9b79Awarding agency National Science Foundation

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
PhaseBio Pharmaceuticals Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
MLJSHGTEWU43
Solicitation number
Not reported
Topic code
Not reported

Research abstract

This Small Business Innovation Research (SBIR) Phase I project proposes develop unique biopolymers as carriers for enzymes used for biocatalysis. Elastin-like polypeptides (ELPs) are a new class of biopolymers, which undergo a reversible, inverse phase transition. When coupled to enzymes as a fusion partner, the ELP can act as a soluble carrier for performing biocatalysis (below the transition temperature) and an insoluble carrier for isolation and recovery of the enzyme (above the transition temperature). The research objectives of the Phase I project include : (1) Design and synthesis of a series of ELP enzyme carriers, each with different properties ; (2) Expression and characterization of ELP enzyme carriers in terms of transition temperature and salt susceptibility ; (3) Optimization of expression and purification of recombinant glycosylation enzyme-ELP carrier fusion proteins in terms of soluble protein, and (4) Quantitation and optimization of glycosylation enzyme activity for the fusion protein relative to native enzyme and extent of recovery of enzyme post-phase transition. The commercial application of this project is in the area of enzymes as relevant to the markets for food manufacturing and fine chemicals. Examples include production of sweeteners and antibiotics. Additional applications are expected in the area of protein therapeutics.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

6 SBIR/STTR records share this UEI (2003–2018). Reported award amounts total $3,687,390. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.